Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy
Overview
This paper outlines a pragmatic randomized controlled trial investigating the impact of treatment dosage (25 versus 50 sessions) on patients with comorbid depression and personality disorders. The study compares schema therapy against short-term psychodynamic supportive psychotherapy to assess clinical outcomes, including depression severity and quality of life, alongside an economic evaluation. It is designed for researchers or clinicians interested in the methodological framework and objectives of this specific factorial trial.
- ID
5eaf9e188a6d4655- Source org
- OpenAlex
- Author
- Not recorded
- Published
- Not recorded
- OA status
- Not recorded
- DOI
- 10.1186/s12888-018-1829-1
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- Not recorded
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 0.95 · checked_at unknown
- linkok via http-check · 2026-07-28T03:58:44.050956+00:00
Cite this entry
BibTeX
@article{allodium:5eaf9e188a6d4655,
title = {Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy},
journal = {OpenAlex},
doi = {10.1186/s12888-018-1829-1},
url = {https://doi.org/10.1186/s12888-018-1829-1}
}RIS
TY - JOUR TI - Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy PB - OpenAlex DO - 10.1186/s12888-018-1829-1 UR - https://doi.org/10.1186/s12888-018-1829-1 ER -
APA
Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy. (n.d.). OpenAlex. https://doi.org/10.1186/s12888-018-1829-1
Related entries
- Design of a multicentered randomized controlled trial on the clinical and cost effectiveness of schema therapy for personality disorders
- Long-term dosage effects of psychodynamic and schema therapy in depressed patients with personality disorders: 18 and 24 months follow-up of a randomized controlled trial
- Combination Psychotherapy and Antidepressant Medication Treatment for Depression: For Whom, When, and How
- The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis
- Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT
- Group schema-focused therapy enriched with psychomotor therapy versus treatment as usual for older adults with cluster B and/or C personality disorders: a randomized trial
- European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe
- Tracking Functional Brain Changes in Patients with Depression under Psychodynamic Psychotherapy Using Individualized Stimuli
- Psychotherapy for subclinical depression: meta-analysis
- Effectiveness of psychotherapy for treatment-resistant depression: a meta-analysis and meta-regression